Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis
Clinical trial NCT01091051 · TERMINATED
Trial details
- NCT number
- NCT01091051
- Sponsor
- Innovaderm Research Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-08-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.